Clinical trial
Docetaxel in Treating Patients With Metastatic Breast Cancer
NCT00008411 · M.D. Anderson Cancer Center, Other · Completed
Key facts
| NCT number | NCT00008411 |
|---|---|
| Title | Docetaxel in Treating Patients With Metastatic Breast Cancer |
| Official title | Phase III Study Comparing the Use of Docetaxel on a Every Three-Week vs. Weekly Schedule in the Treatment of Patients With Metastatic Breast Cancer |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | Docetaxel |
| Enrollment | 90 |
| Start date | Dec 1, 1999 |
| Primary completion | Mar 1, 2006 |
| Completion | Jan 1, 2007 |
| First posted | Jan 27, 2003 |
| Last update posted | Jul 30, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: